(NTNX) Nutanix - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US67059N1081
Stock: Cloud Platform, Infrastructure, Storage, Security
Total Rating 40
Risk 42
Buy Signal -0.41
| Risk 5d forecast | |
|---|---|
| Volatility | 42.5% |
| Relative Tail Risk | -6.93% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.11 |
| Alpha | -65.72 |
| Character TTM | |
|---|---|
| Beta | 1.056 |
| Beta Downside | 0.964 |
| Drawdowns 3y | |
|---|---|
| Max DD | 55.63% |
| CAGR/Max DD | 0.31 |
EPS (Earnings per Share)
Revenue
Description: NTNX Nutanix March 04, 2026
Nutanix, Inc. (NTNX) provides an enterprise cloud platform globally. Its core offerings include hyperconverged infrastructure (HCI) software and a comprehensive cloud platform designed for hybrid multicloud environments. The companys business model focuses on selling software and services for data center modernization and cloud adoption.
Key products include Nutanix Cloud Platform, Nutanix Cloud Infrastructure, and Nutanix Central for managing hybrid multicloud operations. The company also offers specialized solutions like Nutanix Kubernetes Platform for application development and Nutanix Unified Storage for various data types. The enterprise software sector is characterized by recurring revenue models through subscriptions and licenses.
Nutanix provides product support, consulting, and implementation services across diverse industries such as financial services, manufacturing, and healthcare. The companys focus on hybrid multicloud solutions addresses a growing market need for flexible and scalable IT infrastructure. Understanding the competitive landscape and market share within the cloud infrastructure sector is crucial for evaluating NTNX. For further detailed analysis, ValueRay offers in-depth financial and operational data.
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income: 267.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.24 > 0.02 and ΔFCF/TA 2.25 > 1.0 |
| NWC/Revenue: 36.33% < 20% (prev 37.29%; Δ -0.97% < -1%) |
| CFO/TA 0.25 > 3% & CFO 832.2m > Net Income 267.1m |
| Net Debt (939.6m) to EBITDA (337.2m): 2.79 < 3 |
| Current Ratio: 1.65 > 1.5 & < 3 |
| Outstanding Shares: last quarter (294.2m) vs 12m ago 0.29% < -2% |
| Gross Margin: 87.14% > 18% (prev 0.86%; Δ 8628 % > 0.5%) |
| Asset Turnover: 85.72% > 50% (prev 77.56%; Δ 8.16% > 0%) |
| Interest Coverage Ratio: 12.57 > 6 (EBITDA TTM 337.2m / Interest Expense TTM 21.0m) |
Altman Z'' -3.71
| A: 0.30 (Total Current Assets 2.47b - Total Current Liabilities 1.49b) / Total Assets 3.28b |
| B: -1.52 (Retained Earnings -4.99b / Total Assets 3.28b) |
| C: 0.08 (EBIT TTM 264.5m / Avg Total Assets 3.13b) |
| D: -1.21 (Book Value of Equity -4.98b / Total Liabilities 4.11b) |
| Altman-Z'' Score: -3.71 = D |
Beneish M -3.49
| DSRI: 0.67 (Receivables 260.6m/335.5m, Revenue 2.69b/2.32b) |
| GMI: 0.98 (GM 87.14% / 85.82%) |
| AQI: 0.80 (AQ_t 0.15 / AQ_t-1 0.19) |
| SGI: 1.16 (Revenue 2.69b / 2.32b) |
| TATA: -0.17 (NI 267.1m - CFO 832.2m) / TA 3.28b) |
| Beneish M-Score: -3.49 (Cap -4..+1) = AA |
What is the price of NTNX shares?
As of March 07, 2026, the stock is trading at USD 39.83 with a total of 5,697,008 shares traded.
Over the past week, the price has changed by +4.05%, over one month by -1.07%, over three months by -15.95% and over the past year by -44.18%.
Over the past week, the price has changed by +4.05%, over one month by -1.07%, over three months by -15.95% and over the past year by -44.18%.
Is NTNX a buy, sell or hold?
Nutanix has received a consensus analysts rating of 4.35.
Therefore, it is recommended to buy NTNX.
- StrongBuy: 8
- Buy: 7
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the NTNX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 58.9 | 47.8% |
| Analysts Target Price | 58.9 | 47.8% |
NTNX Fundamental Data Overview March 05, 2026
P/E Trailing = 53.5526
P/E Forward = 22.779
P/S = 4.0978
P/EG = 1.0839
Revenue TTM = 2.69b USD
EBIT TTM = 264.5m USD
EBITDA TTM = 337.2m USD
Long Term Debt = 1.34b USD (from longTermDebt, last fiscal year)
Short Term Debt = 33.1m USD (from shortTermDebt, last quarter)
Debt = 1.54b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 939.6m USD (from netDebt column, last quarter)
Enterprise Value = 10.67b USD (11.01b + Debt 1.54b - CCE 1.87b)
Interest Coverage Ratio = 12.57 (Ebit TTM 264.5m / Interest Expense TTM 21.0m)
EV/FCF = 13.74x (Enterprise Value 10.67b / FCF TTM 777.1m)
FCF Yield = 7.28% (FCF TTM 777.1m / Enterprise Value 10.67b)
FCF Margin = 28.94% (FCF TTM 777.1m / Revenue TTM 2.69b)
Net Margin = 9.95% (Net Income TTM 267.1m / Revenue TTM 2.69b)
Gross Margin = 87.14% ((Revenue TTM 2.69b - Cost of Revenue TTM 345.5m) / Revenue TTM)
Gross Margin QoQ = 87.39% (prev 86.96%)
Tobins Q-Ratio = 3.26 (Enterprise Value 10.67b / Total Assets 3.28b)
Interest Expense / Debt = 0.05% (Interest Expense 745.0k / Debt 1.54b)
Taxrate = 11.00% (23.3m / 211.6m)
NOPAT = 235.4m (EBIT 264.5m * (1 - 11.00%))
Current Ratio = 1.65 (Total Current Assets 2.47b / Total Current Liabilities 1.49b)
Debt / Equity = -1.86 (negative equity) (Debt 1.54b / totalStockholderEquity, last quarter -831.3m)
Debt / EBITDA = 2.79 (Net Debt 939.6m / EBITDA 337.2m)
Debt / FCF = 1.21 (Net Debt 939.6m / FCF TTM 777.1m)
Total Stockholder Equity = -726.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 8.53% (Net Income 267.1m / Total Assets 3.28b)
RoE = -36.77% (negative equity) (Net Income TTM 267.1m / Total Stockholder Equity -726.5m)
RoCE = 42.85% (EBIT 264.5m / Capital Employed (Equity -726.5m + L.T.Debt 1.34b))
RoIC = 36.09% (NOPAT 235.4m / Invested Capital 652.3m)
WACC = 8.61% (E(11.01b)/V(12.55b) * Re(9.81%) + D(1.54b)/V(12.55b) * Rd(0.05%) * (1-Tc(0.11)))
Discount Rate = 9.81% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.93%
[DCF] Terminal Value 79.31% ; FCFF base≈722.9m ; Y1≈891.7m ; Y5≈1.52b
[DCF] Fair Price = 80.99 (EV 22.84b - Net Debt 939.6m = Equity 21.90b / Shares 270.4m; r=8.61% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 88.40 | EPS CAGR: 54.48% | SUE: 2.19 | # QB: 1
Revenue Correlation: 97.33 | Revenue CAGR: 16.81% | SUE: 1.82 | # QB: 1
EPS next Quarter (2026-04-30): EPS=0.35 | Chg7d=-0.082 | Chg30d=-0.080 | Revisions Net=-12 | Analysts=15
EPS current Year (2026-07-31): EPS=1.82 | Chg7d=+0.011 | Chg30d=+0.026 | Revisions Net=+5 | Growth EPS=+12.4% | Growth Revenue=+11.4%
EPS next Year (2027-07-31): EPS=2.16 | Chg7d=-0.007 | Chg30d=-0.012 | Revisions Net=-2 | Growth EPS=+18.5% | Growth Revenue=+13.4%
[Analyst] Revisions Ratio: -1.00 (0 Up / 12 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 7.9% (Discount Rate 9.8% - Earnings Yield 1.9%)
[Growth] Growth Spread = -0.5% (Analyst 7.5% - Implied 7.9%)
P/E Forward = 22.779
P/S = 4.0978
P/EG = 1.0839
Revenue TTM = 2.69b USD
EBIT TTM = 264.5m USD
EBITDA TTM = 337.2m USD
Long Term Debt = 1.34b USD (from longTermDebt, last fiscal year)
Short Term Debt = 33.1m USD (from shortTermDebt, last quarter)
Debt = 1.54b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 939.6m USD (from netDebt column, last quarter)
Enterprise Value = 10.67b USD (11.01b + Debt 1.54b - CCE 1.87b)
Interest Coverage Ratio = 12.57 (Ebit TTM 264.5m / Interest Expense TTM 21.0m)
EV/FCF = 13.74x (Enterprise Value 10.67b / FCF TTM 777.1m)
FCF Yield = 7.28% (FCF TTM 777.1m / Enterprise Value 10.67b)
FCF Margin = 28.94% (FCF TTM 777.1m / Revenue TTM 2.69b)
Net Margin = 9.95% (Net Income TTM 267.1m / Revenue TTM 2.69b)
Gross Margin = 87.14% ((Revenue TTM 2.69b - Cost of Revenue TTM 345.5m) / Revenue TTM)
Gross Margin QoQ = 87.39% (prev 86.96%)
Tobins Q-Ratio = 3.26 (Enterprise Value 10.67b / Total Assets 3.28b)
Interest Expense / Debt = 0.05% (Interest Expense 745.0k / Debt 1.54b)
Taxrate = 11.00% (23.3m / 211.6m)
NOPAT = 235.4m (EBIT 264.5m * (1 - 11.00%))
Current Ratio = 1.65 (Total Current Assets 2.47b / Total Current Liabilities 1.49b)
Debt / Equity = -1.86 (negative equity) (Debt 1.54b / totalStockholderEquity, last quarter -831.3m)
Debt / EBITDA = 2.79 (Net Debt 939.6m / EBITDA 337.2m)
Debt / FCF = 1.21 (Net Debt 939.6m / FCF TTM 777.1m)
Total Stockholder Equity = -726.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 8.53% (Net Income 267.1m / Total Assets 3.28b)
RoE = -36.77% (negative equity) (Net Income TTM 267.1m / Total Stockholder Equity -726.5m)
RoCE = 42.85% (EBIT 264.5m / Capital Employed (Equity -726.5m + L.T.Debt 1.34b))
RoIC = 36.09% (NOPAT 235.4m / Invested Capital 652.3m)
WACC = 8.61% (E(11.01b)/V(12.55b) * Re(9.81%) + D(1.54b)/V(12.55b) * Rd(0.05%) * (1-Tc(0.11)))
Discount Rate = 9.81% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.93%
[DCF] Terminal Value 79.31% ; FCFF base≈722.9m ; Y1≈891.7m ; Y5≈1.52b
[DCF] Fair Price = 80.99 (EV 22.84b - Net Debt 939.6m = Equity 21.90b / Shares 270.4m; r=8.61% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 88.40 | EPS CAGR: 54.48% | SUE: 2.19 | # QB: 1
Revenue Correlation: 97.33 | Revenue CAGR: 16.81% | SUE: 1.82 | # QB: 1
EPS next Quarter (2026-04-30): EPS=0.35 | Chg7d=-0.082 | Chg30d=-0.080 | Revisions Net=-12 | Analysts=15
EPS current Year (2026-07-31): EPS=1.82 | Chg7d=+0.011 | Chg30d=+0.026 | Revisions Net=+5 | Growth EPS=+12.4% | Growth Revenue=+11.4%
EPS next Year (2027-07-31): EPS=2.16 | Chg7d=-0.007 | Chg30d=-0.012 | Revisions Net=-2 | Growth EPS=+18.5% | Growth Revenue=+13.4%
[Analyst] Revisions Ratio: -1.00 (0 Up / 12 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 7.9% (Discount Rate 9.8% - Earnings Yield 1.9%)
[Growth] Growth Spread = -0.5% (Analyst 7.5% - Implied 7.9%)